No relationship between vasoactive intestinal polypeptide expression and headache in pituitary tumours

Acta Neurologica Scandinavica

Volumn 111, Issue 5, 2005, Pages 317-322

  Nathoo, S ^a   Classey, J D ^a   Levy, M J ^a,b   Meeran, K ^b   Powell, M ^c   Goadsby, P J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Headache; Migraine; Pituitary tumour; Trigeminovascular

Indexed keywords

VASOACTIVE INTESTINAL POLYPEPTIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; HEADACHE; HUMAN; HUMAN TISSUE; HYPOPHYSIS CELL; HYPOPHYSIS TUMOR; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS;

BIOLOGICAL MARKERS; FEMALE; HEADACHE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; PITUITARY NEOPLASMS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 17644425317     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2005.00412.x     Document Type: Article

References (33)

1. ABE T, MATSUMOTO K, KUWAZAWA J, TOYODA I, SASAKI K. Headache associated with pituitary adenomas. Headache 1998;38:782-6.
2. LEVY MJ, JAGER HR, MATHARU MS, GOADSBY PJ. Pituitary tumours and headache: does size matter? Cephalalgia 2002;22:592.
3. EDVINSSON L, GOADSBY PJ. Neuropeptides in the cerebral circulation: relevance to headache. Cephalalgia 1995;15:272-8.
4. BESSON J, SARRIEAU A, VIAL M, MARIE JC, ROSSELIN G, ROSTENE W. Characterization and autoradiographic distribution of vasoactive intestinal peptide binding sites in the rat central nervous system. Brain Res 1986;398:329-36.
5. FAHRENKRUO J, EMSON P. Vasoactive intestinal polypeptide: functional aspects. Med Bull 1982;38:265-70.
6. KOVES K, GOTTSCHALL PE, GORCS T, SCAMMEL J, ARIMURA A. Presence of immunoreactive vasoactive intestinal polypeptide in anterior pituitary of normal male and long term estrogen-treated female rats: a light microscope immunohistochemical study. Endocrinology 1990;126:1756-63.
7. ARNAOUT M, GARTHWAITE T, MARTINSON D, HAGEN T. Vasoactive intestinal polypeptide is synthesised in anterior pituitary tissue. Endocrinology 1986;119:2052-7.
8. OKA H, JIN L, REUBI J et al. PACAP binding sites and PACAP/vasoactive intestinal polypeptide receptor expression in human pituitary adenomas. Am J Pathol 1998;153:1787-96.
9. HSU D, RISKIND P, MEDLEY-WHITE T. Vasoactive intestinal polypeptide in the human pituitary gland and adenomas. Am J Pathol 1989;135:329-38.
10. COUCH J. Toxic and metabolic headache. Handbook of clinical neurology. Amsterdam: Elsevier. 1986;417-30.
11. MCNAUGHTON FL. The innervation of the intracranial blood vessels and the dural sinuses. In: COBB S, FRANTZ AM. PENFIELD W, RILEY HA, eds. The circulation of the brain and spinal cord. New York: Hafner Publishing Co. Inc., 1966;178-200.
12. PENFIELD W, MCNAUCHTON FL. Dural headache and the innervation of the dura mater. Arch Neurol Psychiatry 1940;44:43-75.
13. MAY A, GOADSBY PJ. The trigeminovascular system in humans: pathophysiological implications for primary headache syndromes of the neural influences on the cerebral circulation. J Cereb Blood Flow Metab 1999;19:115-27.
14. GOADSBY PJ, EDVINSSON L. Human in vivo evidence for trigeminovascular activation in cluster headache. Brain 1994;117:427-34.
15. NATHOO S, CLASSEY J, LEVY M, POWELL M, MEERAN K, GOADSBY PJ. Vasoactive intestinal polypeptide expressed in pituitary tumours does not account for headache: a clinical-pathological correlation. Cephalalgia 2004;24:789-90.
16. LEVY M, JAGER HR, POWELL MP, MATHARU MS, MEERAN K, GOADSBY PJ. Pituitary volume and headache: size is not everything. Arch Neurol 2004;61:721-5.
17. LEVY MJ, MATHARU MS, POWELL MP, MEERAN K, GOADSBY PJ. Phenotypic characterisation of the headache associated with pituitary tumours. Cephalalgia 2003;23:621.
18. DICKINSON T, FLEETWOOD-WALKER S. VIP and PACAP: very important in pain? Trends Pharmacol Sci 1999;20:324-9.
19. HÖKFELT T, ZHANO X, WIESENFELD-HALLIN Z. Messenger plasticity in primary sensory neurons following axotomy and its functional implications. Trends Neurosci 1994;17:22-30.
20. KIM HJ, BACK S, KIM J, SUNG B, HONG SK, NA HS. Increases in spinal vasoactive intestinal polypeptide and neuropeptide Y are not sufficient for the genesis of neuropathic pain in rats. Neurosci Lett 2003;342:109-13.
21. NOGUCHI K, SENBA E, MONTA Y, SATO M, TOHYAMA M. Prepro-VIP and preprotachykinin mRNAs in the dorsal root ganglion cells following peripheral axotomy. Mol Brain Res 1989;6:327-30.
22. SIMS KB, HOMAN D, SAID S, ZIMMERMAN E. Vasoactive intestinal polypeptide in mouse and rat brain: an immunocytochemical study. Brain Res 1980;186:165-83.
23. GOADSBY PJ, LIFTON RB, FERRARI MD. Migraine - current understanding and treatment. N Engl J Med 2002;346:257-70.
24. GOADSBY PJ. Pathophysiology of cluster headache: a trigeminal autonomic cephalgia. Lancet Neurol 2002;1:37-43.
25. LEONE M, BUSSONE G. A review of hormonal findings in cluster headache. Evidence for hypothalamic involvement. Cephalalgia 1993;13:309-17.
26. GIN NJ, RUCCIERO L, LIPTON RB et al. Premonitory symptoms in migraine: an electronic diary study. Neurology 2003;60:935-40.
27. SILBERSTEIN SD, DE LIGNIERES B. Migraine, menopause and hormonal replacement therapy. Cephalalgia 2000;20:214-21.
28. ARAFAH BM, PRUNTY D, YBARRA J, HLAVIN ML, SELMAN WR. The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas. J Endocrinol Metab 2000;85:1789-93.
29. WILLIAMS G, BALL JA, LAWSON RA, JOPLIN GF, BLOOM SR, MASKILL MR. Analgesic effect of somatostatin analogue (octreotide) in headache associated with pituitary tumours. Br Med J 1987;295:247-8.
30. LEVY MJ, BARAKAT M, BOON P, GOADSBY PJ, MEERAN K. Acromegaly: a unique human headache model? Headache 2003;43:794-7.
31. OLESEN J, DIENER H-C, HUSSTEDT I-W et al. Calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS is effective in the treatment of migraine attacks. N Engl J Med 2004;350:1104-10.
32. LEVY MJ, CLASSEY JD, MANEESRI S, POWELL M, MEERAN K, GOADSBY PJ. The association between calcitonin gene-related peptide (CGRP), substance P and headache in pituitary tumours. Pituitary 2004;7:67-71.
33. CLASSEY JD, LEVY MJ, POWELL M, GROUZMANN E, MEERAN K, GOADSBY PJ. Comparative expression of neuropeptide Y (NPY) and orexin B (Orx B) in the anterior pituitary (AP) tumours of patients suffering from migraine-like headache. Cephalalgia 2003;23:687.